Atea Pharmaceuticals Cash from Financing (TTM) Trends

Atea Pharmaceuticals Inc (AVIR)

3.705 +0.02 (+0.41%) USD | NASDAQ | Apr 26, 16:00

3.705 0.00 (0.00%) After-Hours: 19:53

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	0.257M
September 30, 2023	0.257M
June 30, 2023	0.312M
March 31, 2023	0.312M
December 31, 2022	0.37M
September 30, 2022	0.512M
June 30, 2022	1.16M

Date	Value
March 31, 2022	1.217M
December 31, 2021	1.465M
September 30, 2021	427.54M
June 30, 2021	425.83M
March 31, 2021	532.22M
December 31, 2020	531.75M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.257M

Minimum

Sep 2023

532.22M

Maximum

Mar 2021

147.94M

Average

1.16M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks